Indian Generic Drug

Jump to

Indian drug makers can export patented meds for approval: HC

The ruling came as the court allowed state-run pharma company Natco and generic drug maker Alembic Pharmaceuticals to export two patented medicines of German drug major Bayer's for clinical trials and regulatory approvals abroad as allowed under section 107A of the Patents Act.
BDR Pharma lines up more compulsory licences: Sources

Indian generic drug maker BDR Pharma's plans could draw new battles lines over intellectual property rights. After seeking a compulsory license for leukemia drug Sprycel, BDR Pharma is setting its sight on more patent-protected anti-cancer drugs, reports CNBC-TV18's Archana Shukla.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347

Indian Generic Drug

Indian drug makers can export patented meds for approval: HC

BDR Pharma lines up more compulsory licences: Sources